Hong Kong stocks are active. Stone Pharmaceutical Biotechnology-B (02616.HK) surged more than 4% in the morning, and the company plans to raise a net amount of HK$472 million through a rights issue for use in clinical research and development such as CS2009.
According to the Jrj.com.cn APP, Brickell Biotech-B (02616.HK) rose more than 4% in the morning, as of the time of writing, it was up 3.08% at 5.36 Hong Kong dollars, with a trading volume of 26.7035 million Hong Kong dollars.
Latest
